tradingkey.logo
搜索

Anbio Biotechnology

NNNN
添加自选
26.950USD
+1.880+7.50%
交易中 美东报价延迟15分钟
1.18B总市值
183.80市盈率 TTM

Anbio Biotechnology

26.950
+1.880+7.50%

关于 Anbio Biotechnology 公司

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).

Anbio Biotechnology简介

公司代码NNNN
公司名称Anbio Biotechnology
上市日期Feb 19, 2025
CEOLau (Michael)
员工数量27
证券类型Ordinary Share
年结日Feb 19
公司地址Friedrich-Ebert-Anlage 49
城市FRANKFURT AM MAIN
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Germany
邮编60308
电话4916096247281
网址https://anbiobiotechnology.com/
公司代码NNNN
上市日期Feb 19, 2025
CEOLau (Michael)

Anbio Biotechnology公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--
Mr. David Hsu
Mr. David Hsu
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Michael Lau
Mr. Michael Lau
Chief Executive Officer
Chief Executive Officer
--
--
Ms. Suki Song
Ms. Suki Song
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Chris Tiantian
Mr. Chris Tiantian
Chief Business Officer
Chief Business Officer
--
--
Mr. Cany Xu
Mr. Cany Xu
Executive Director
Executive Director
--
--
Ms. Nancy Hartzler
Ms. Nancy Hartzler
Independent Director
Independent Director
--
--
Mr. Kenneth Li
Mr. Kenneth Li
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 4月6日 周一
单位: USD更新时间: 4月6日 周一
FY2024
FY2023
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
European Union
5.62M
68.64%
South America
1.48M
18.02%
Asia Pacific
509.17K
6.22%
Other Regions
472.38K
5.77%
North America
110.51K
1.35%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 4月21日 周二
更新时间: 4月21日 周二
持股股东
股东类型
持股股东
持股股东
占比
Northwestern Mutual Capital, LLC
4.78%
CVC Investment
4.78%
Geode Capital Management, L.L.C.
0.06%
BNP Paribas Securities Corp. North America
0.02%
UBS Financial Services, Inc.
0.01%
其他
90.33%
持股股东
持股股东
占比
Northwestern Mutual Capital, LLC
4.78%
CVC Investment
4.78%
Geode Capital Management, L.L.C.
0.06%
BNP Paribas Securities Corp. North America
0.02%
UBS Financial Services, Inc.
0.01%
其他
90.33%
股东类型
持股股东
占比
Investment Advisor
4.80%
Corporation
4.78%
Investment Advisor/Hedge Fund
0.06%
其他
90.36%

机构持股

更新时间: 4月1日 周三
更新时间: 4月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q1
13
2.13M
4.86%
+2.06M
2025Q4
12
2.17M
4.94%
+2.15M
2025Q3
8
2.13M
4.85%
+2.06M
2025Q2
5
4.27M
9.72%
+4.25M
2025Q1
5
4.27M
9.72%
+4.27M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Northwestern Mutual Capital, LLC
2.10M
4.78%
+2.10M
--
Feb 19, 2025
CVC Investment
2.10M
4.78%
+2.10M
--
Feb 19, 2025
Geode Capital Management, L.L.C.
25.76K
0.06%
--
--
Dec 31, 2025
BNP Paribas Securities Corp. North America
1.00K
0%
-1.42K
-58.66%
Dec 31, 2025
UBS Financial Services, Inc.
2.85K
0.01%
+1.89K
+196.77%
Dec 31, 2025
Wells Fargo Advisors
100.00
0%
--
--
Dec 31, 2025
Morgan Stanley & Co. LLC
28.00
0%
-8.58K
-99.67%
Dec 31, 2025
Invesco Capital Management LLC
35.00
0%
--
--
Feb 28, 2026
Marshall Wace LLP
--
0%
-10.44K
-100.00%
Dec 31, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI